Functional mitral regurgitation: Current understanding and approach to management

Canadian Journal of Cardiology

Volumn 30, Issue 2, 2014, Pages 173-180

  Ducas, Robin A ^a   White, Christopher W ^a   Wassef, Anthony W ^a   Farag, Ashraf ^a   Bhagirath, Kapil M ^b   Freed, Darren H ^a   Tam, James W ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ECHOCARDIOGRAPHY; EXERCISE; HEART FUNCTION; HUMAN; ISCHEMIC CARDIOMYOPATHY; MITRAL VALVE REGURGITATION; MORBIDITY; MORTALITY; NONISCHEMIC CARDIOMYOPATHY; PATHOPHYSIOLOGY; PHYSICAL EXAMINATION; REVASCULARIZATION; REVIEW; THREE DIMENSIONAL ECHOCARDIOGRAPHY;

ECHOCARDIOGRAPHY; HEART VALVE PROSTHESIS IMPLANTATION; HEART VENTRICLES; HUMANS; MITRAL VALVE INSUFFICIENCY; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 84893021246     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2013.11.022     Document Type: Review

References (60)

1. Chaliki H.P., Nishimura R.A., Enriquez-Sarano M., Reeder G.S. A simplified, practical approach to assessment of severity of mitral regurgitation by Doppler color flow imaging with proximal convergence: validation with concomitant cardiac catheterization. Mayo Clin Proc 1998, 73:929-935.
2. Pierard L.A., Carabello B.A. Ischaemic mitral regurgitation: pathophysiology, outcomes and the conundrum of treatment. Eur Heart J 2010, 31:2996-3005.
3. Vahanian A., Baumgartner H., Bax J., et al. Guidelines on the management of valvular heart disease: the Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 2007, 28:230-268.
4. Perez de Isla L., Zamorano J., Martinez Quesada M., et al. Prognostic significance of ischemic mitral regurgitation after non-Q-wave acute myocardial infarction. J Heart Valve Dis 2005, 14:742-748.
5. de Marchena E., Badiye A., Robalino G., et al. Respective prevalence of the different Carpentier classes of mitral regurgitation: a stepping stone for future therapeutic research and development. J Card Surg 2011, 26:385-392.
6. Grigioni F., Enriquez-Sarano M., Zehr K.J., Bailey K.R., Tajik A.J. Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment. Circulation 2001, 103:1759-1764.
7. He S., Fontaine A.A., Schwammenthal E., Yoganathan A.P., Levine R.A. Integrated mechanism for functional mitral regurgitation: leaflet restriction versus coapting force: in vitro studies. Circulation 1997, 96:1826-1834.
8. Yiu S.F., Enriquez-Sarano M., Tribouilloy C., Seward J.B., Tajik A.J. Determinants of the degree of functional mitral regurgitation in patients with systolic left ventricular dysfunction: A quantitative clinical study. Circulation 2000, 102:1400-1406.
9. Chaput M., Handschumacher M.D., Tournoux F., et al. Mitral leaflet adaptation to ventricular remodeling: occurrence and adequacy in patients with functional mitral regurgitation. Circulation 2008, 118:845-852.
10. Schmitto J.D., Lee L.S., Mokashi S.A., et al. Functional mitral regurgitation. Cardiol Rev 2010, 18:285-291.
11. Enriquez-Sarano M., Rossi A., Seward J.B., Bailey K.R., Tajik A.J. Determinants of pulmonary hypertension in left ventricular dysfunction. J Am Coll Cardiol 1997, 29:153-159.
12. Gaasch W.H., Meyer T.E. Left ventricular response to mitral regurgitation: implications for management. Circulation 2008, 118:2298-2303.
13. van Rijk-Zwikker G.L., Delemarre B.J., Huysmans H.A. Mitral valve anatomy and morphology: relevance to mitral valve replacement and valve reconstruction. J Card Surg 1994, 9:255-261.
14. Lancellotti P., Moura L., Pierard L.A., et al. European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease). Eur J Echocardiogr 2010, 11:307-332.
15. Lancellotti P., Stainier P.Y., Lebois F., Pierard L.A. Effect of dynamic left ventricular dyssynchrony on dynamic mitral regurgitation in patients with heart failure due to coronary artery disease. Am J Cardiol 2005, 96:1304-1307.
16. Hung C.L., Tien S.L., Lo C.I., et al. The incremental value of regional dyssynchrony in determining functional mitral regurgitation beyond left ventricular geometry after narrow QRS anterior myocardial infarction: a real time three-dimensional echocardiography study. Echocardiography 2011, 28:665-675.
17. Breithardt O.A., Sinha A.M., Schwammenthal E., et al. Acute effects of cardiac resynchronization therapy on functional mitral regurgitation in advanced systolic heart failure. J Am Coll Cardiol 2003, 41:765-770.
18. van Bommel R.J., Marsan N.A., Delgado V., et al. Cardiac resynchronization therapy as a therapeutic option in patients with moderate-severe functional mitral regurgitation and high operative risk. Circulation 2011, 124:912-919.
19. Madaric J., Vanderheyden M., Van Laethem C., et al. Early and late effects of cardiac resynchronization therapy on exercise-induced mitral regurgitation: relationship with left ventricular dyssynchrony, remodelling and cardiopulmonary performance. Eur Heart J 2007, 28:2134-2141.
20. Di Mauro M., Gallina S., D'Amico M.A., et al. Functional mitral regurgitation: from normal to pathological anatomy of mitral valve. Int J Cardiol 2013, 163:242-248.
21. Messas E., Guerrero J.L., Handschumacher M.D., et al. Paradoxic decrease in ischemic mitral regurgitation with papillary muscle dysfunction: insights from three-dimensional and contrast echocardiography with strain rate measurement. Circulation 2001, 104:1952-1957.
22. Chinitz J.S., Chen D., Goyal P., et al. Mitral apparatus assessment by delayed enhancement CMR: relative impact of infarct distribution on mitral regurgitation. JACC Cardiovas Imaging 2013, 6:220-234.
23. Beaudoin J., Handschumacher M.D., Zeng X., et al. Mitral valve enlargement in chronic aortic regurgitation as a compensatory mechanism to prevent functional mitral regurgitation in the dilated left ventricle. J Am Coll Cardiol 2013, 61:1809-1816.
24. Desjardins V.A., Enriquez-Sarano M., Tajik A.J., Bailey K.R., Seward J.B. Intensity of murmurs correlates with severity of valvular regurgitation. Am J Med 1996, 100:149-156.
25. Bouma W., van der Horst I.C., Wijdh-den Hamer I.J., et al. Chronic ischaemic mitral regurgitation. Current treatment results and new mechanism-based surgical approaches. Eur J Cardiothorac Surg 2010, 37:170-185.
26. Bonow R.O., Carabello B.A., Chatterjee K., et al. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 2008, 118:e523-e661.
27. Thomas L., Foster E., Schiller N.B. Peak mitral inflow velocity predicts mitral regurgitation severity. J Am Coll Cardiol 1998, 31:174-179.
28. Crestanello J.A. Surgical approach to mitral regurgitation in chronic heart failure: when is it an optionα. Curr Heart Fail Rep 2012, 9:40-50.
29. Ypenburg C., Lancellotti P., Tops L.F., et al. Acute effects of initiation and withdrawal of cardiac resynchronization therapy on papillary muscle dyssynchrony and mitral regurgitation. J Am Coll Cardiol 2007, 50:2071-2077.
30. Ennezat P.V., Marechaux S., Le Tourneau T., et al. Myocardial asynchronism is a determinant of changes in functional mitral regurgitation severity during dynamic exercise in patients with chronic heart failure due to severe left ventricular systolic dysfunction. Eur Heart J 2006, 27:679-683.
31. Lafitte S., Bordachar P., Lafitte M., et al. Dynamic ventricular dyssynchrony: an exercise-echocardiography study. J Am Coll Cardiol 2006, 47:2253-2259.
32. Izumo M., Suzuki K., Moonen M., et al. Changes in mitral regurgitation and left ventricular geometry during exercise affect exercise capacity in patients with systolic heart failure. Eur J Echocardiogr 2011, 12:54-60.
33. Yamano T., Nakatani S., Kanzaki H., et al. Exercise-induced changes of functional mitral regurgitation in asymptomatic or mildly symptomatic patients with idiopathic dilated cardiomyopathy. Am J Cardiol 2008, 102:481-485.
34. Pierard L.A., Lancellotti P. The role of ischemic mitral regurgitation in the pathogenesis of acute pulmonary edema. N Engl J Med 2004, 351:1627-1634.
35. Takano H., Adachi H., Ohshima S., Taniguchi K., Kurabayashi M. Functional mitral regurgitation during exercise in patients with heart failure. Circ J 2006, 70:1563-1567.
36. Lancellotti P., Gerard P.L., Pierard L.A. Long-term outcome of patients with heart failure and dynamic functional mitral regurgitation. Eur Heart J 2005, 26:1528-1532.
37. Marechaux S., Pincon C., Gal B., et al. Functional mitral regurgitation at rest determines the acute hemodynamic response to cardiac resynchronization therapy during exercise: an acute exercise echocardiographic study. J Am Soc Echocardiogr 2009, 22:464-471.
38. Kwan J., Shiota T., Agler D.A., et al. Geometric differences of the mitral apparatus between ischemic and dilated cardiomyopathy with significant mitral regurgitation: real-time three-dimensional echocardiography study. Circulation 2003, 107:1135-1140.
39. Song J.M., Kim M.J., Kim Y.J., et al. Three-dimensional characteristics of functional mitral regurgitation in patients with severe left ventricular dysfunction: a real-time three-dimensional colour Doppler echocardiography study. Heart 2008, 94:590-596.
40. Arnold J.M., Liu P., Demers C., et al. Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: diagnosis and management. Can J Cardiol 2006, 22:23-45.
41. Dickstein K., Cohen-Solal A., Filippatos G., et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 2008, 10:933-989.
42. Seneviratne B., Moore G.A., West P.D. Effect of captopril on functional mitral regurgitation in dilated heart failure: a randomised double blind placebo controlled trial. Br Heart J 1994, 72:63-68.
43. Capomolla S., Febo O., Gnemmi M., et al. Beta-blockade therapy in chronic heart failure: diastolic function and mitral regurgitation improvement by carvedilol. Am Heart J 2000, 139:596-608.
44. Abraham W.T., Fisher W.G., Smith A.L., et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002, 346:1845-1853.
45. Cleland J.G., Daubert J.C., Erdmann E., et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005, 352:1539-1549.
46. Vahanian A., Alfieri O., Andreotti F., et al. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J 2012, 33:2451-2496.
47. Mihaljevic T., Lam B.K., Rajeswaran J., et al. Impact of mitral valve annuloplasty combined with revascularization in patients with functional ischemic mitral regurgitation. J Am Coll Cardiol 2007, 49:2191-2201.
48. McGee E.C., Gillinov A.M., Blackstone E.H., et al. Recurrent mitral regurgitation after annuloplasty for functional ischemic mitral regurgitation. J Thorac Cardiovasc Surg 2004, 128:916-924.
49. Anyanwu A.C., Adams D.H. Why do mitral valve repairs failα. J Am Soc Echocardiogr 2009, 22:1265-1268.
50. Silberman S., Klutstein M.W., Sabag T., et al. Repair of ischemic mitral regurgitation: comparison between flexible and rigid annuloplasty rings. Ann Thorac Surg 2009, 87:1721-1726. [discussion: 6-7].
51. Braun J., van de Veire N.R., Klautz R.J., et al. Restrictive mitral annuloplasty cures ischemic mitral regurgitation and heart failure. Ann Thorac Surg 2008, 85:430-436. [discussion 6-7].
52. Fattouch K., Guccione F., Sampognaro R., et al. POINT: efficacy of adding mitral valve restrictive annuloplasty to coronary artery bypass grafting in patients with moderate ischemic mitral valve regurgitation: a randomized trial. J Thorac Cardiovasc Surg 2009, 138:278-285.
53. O'Gara P.T. Randomized trials in moderate ischemic mitral regurgitation: many questions, limited answers. Circulation 2012, 126:2452-2455.
54. Deja M.A., Grayburn P.A., Sun B., et al. Influence of mitral regurgitation repair on survival in the surgical treatment for ischemic heart failure trial. Circulation 2012, 125:2639-2648.
55. Masson J.B., Webb J.G. Percutaneous mitral annuloplasty. Coron Artery Dis 2009, 20:183-188.
56. Feldman T., Cilingiroglu M. Percutaneous leaflet repair and annuloplasty for mitral regurgitation. J Am Coll Cardiol 2011, 57:529-537.
57. Dubreuil O., Basmadjian A., Ducharme A., et al. Percutaneous mitral valve annuloplasty for ischemic mitral regurgitation: first in man experience with a temporary implant. Catheter Cardiovasc Interv 2007, 69:1053-1061.
58. Schofer J., Siminiak T., Haude M., et al. Percutaneous mitral annuloplasty for functional mitral regurgitation: results of the CARILLON Mitral Annuloplasty Device European Union Study. Circulation 2009, 120:326-333.
59. Webb J.G., Harnek J., Munt B.I., et al. Percutaneous transvenous mitral annuloplasty: initial human experience with device implantation in the coronary sinus. Circulation 2006, 113:851-855.
60. Feldman T., Foster E., Glower D.D., et al. Percutaneous repair or surgery for mitral regurgitation. N Engl J Med 2011, 364:1395-1406.